Before you sell to, join or invest in Vergent Bioscience, Inc.
MentionFox check on Vergent Bioscience, Inc.: only 2 sources on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/vergent-bioscience-inc-form-d-25000002
Check Vergent Bioscience, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Vergent Bioscience, Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Vergent Bioscience, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-02-18.
Vergent Bioscience, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on February 18, 2025. The filing reports $3.75M sold. Its industry group is Biotechnology (SEC Form D/A, February 18, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Vergent Bioscience, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-02-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Vergent Bioscience, Inc.
Free to see. No signup.
More on the people and the money behind Vergent Bioscience, Inc., from the filings we hold.
Biotechnology raises by companies based in Minnesota, filed within 90 days of this one, largest first.
Get an email when Vergent Bioscience, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Vergent Bioscience, Inc. raises, hires or launches. No email unless you switch it on.
Watch Vergent Bioscience, Inc. →Get the full cited report on Vergent Bioscience, Inc.
What the filing shows about Vergent Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vergent Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Vergent Bioscience, Inc.'s address as 5810 W 78TH St, Ste 222, Minneapolis, MN 55439.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-02-18: the figures on this page did not change. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Vergent Bioscience, Inc. See pricing
Vergent Bioscience, Inc. is a registered filer with the SEC (CIK 1741495) and has filed since 2022-10-04. 4 filings are on record, the latest on 2025-10-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Vergent Bioscience, Inc.'s Form D of 2025-02-18 names John Santini, Ryan Egeland, Jeff Julkowski and 6 more as its officers, directors or promoters.
Its new offerings report $43.97M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 765 filings in Biotechnology, totalled by week.
John Santini is named as Executive Officer and Director on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
On the filing as: Director.
Ryan Egeland is named as Mr. Egeland was a Director on the date the board approved the offering. He resigned as a Director on the Date of First Sale. on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
On the filing as: Director.
Jeff Julkowski is named as Mr. Julkowski was a Director on the date the board approved the offering. He resigned as a Director on the Date of First Sale. on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
On the filing as: Director.
Samuel Dean Banks is named as Mr. Dean Banks was a Director on the date the board approved the offering. He resigned as a Director on the Date of First Sale. on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
Douglas Kohrs is named as Director on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
Raymond Wong is named as Director on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
Bobby Helmedag is named as Director on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
On the filing as: Director.
Anita Watkins is named as Ms. Wilson was elected as a Director on the Date of First Sale. on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
Jeffrey Yurecko is named as Executive Officer on the Form D that Vergent Bioscience, Inc. filed with the SEC on 18 February 2025, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2025-02-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Vergent Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vergent Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vergent Bioscience, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Vergent Bioscience, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Vergent Bioscience, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Vergent Bioscience, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Minneapolis-St. Paul
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/vergent-bioscience-inc-form-d-25000002